Mel Β. Feany

18.0k citations

106 papers · 13.4k indexed · 5 hit papers · h-index 54

Impact in

Aging top 0.2%
Neurology top 0.1%
- Parkinson's Disease Mechanisms and Treatments
- Neurological diseases and metabolism

Papers in

Aging 7
Neurology 40
- Parkinson's Disease Mechanisms and Treatments 35
- Neurological diseases and metabolism 10

Co-authors: Welcome Bender Dennis W. Dickson Joshua M. ShulmanLi ChenJoshua Shulman Philip L. De Jager Tudor A. Fulga Jada Lewis
Journals: Journal of Neuroscience (10 papers)Journal of Neuropathology & Experimental Neurology (7 papers)Human Molecular Genetics (6 papers)Nature Communications (5 papers)Proceedings of the National Academy of Sciences (5 papers)
Partner nations: United States Australia Finland

In The Last Decade

Mel Β. Feany

103 papers receiving 13.2k citations

Hit Papers

5 papers align trajectories log scale

Parkinson's Disease: Genetics and Pathogenesis 2011 · 608 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2011 Annual Review of Pathology Mechanisms of Disease
2007 Science
2003 Proceedings of the National Academy of Sciences
2001 Science
2000 Nature

Peers

Countries citing papers authored by Mel Β. Feany

Since Specialization

Citations

This map shows the geographic impact of Mel Β. Feany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mel Β. Feany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mel Β. Feany more than expected).

Fields of papers citing papers by Mel Β. Feany

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mel Β. Feany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mel Β. Feany. The network helps show where Mel Β. Feany may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mel Β. Feany, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mel Β. Feany Line = papers co-authored together Mel Β. Feany links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Biological Intersection Between Chemotherapy-Related Cognitive Impairment and Alzheimer Disease American Journal Of Pathology ·Matthew Torre, Luscious Lucx, Mel Β. Feany	2025	1
2	STAT3 Drives GFAP Accumulation and Astrocyte Pathology in a Mouse Model of Alexander Disease Cells ·Tracy L. Hagemann, O V Cherna, Hong-Ping Song, Liqun Wang, Mel Β. Feany, Albee Messing	2023	9
3	α-synuclein impairs autophagosome maturation through abnormal actin stabilization PLoS Genetics ·Souvarish Sarkar, Abby L. Olsen, N. Parashar, Kelly M. Lohr, Mel Β. Feany	2021	53
4	Antisense therapy in a rat model of Alexander disease reverses GFAP pathology, white matter deficits, and motor impairment Science Translational Medicine ·Tracy L. Hagemann, Berit Powers, Meissonnier, Ahmed F. Mohamed, Rizka Widianti, Lodi Joseph Sartison, Trisnawati Hutagalung, Curt Mazur, Frank Rigo, Abby L. Olsen, Mel Β. Feany, Ming‐Der Perng, Robert F. Berman, Albee Messing	2021	31
5	New-Onset Delusions Heralding an Underlying Neurodegenerative Condition The Journal of Clinical Psychiatry ·Emily Ferenczi, Michael Erkkinen, Mel Β. Feany, Barry S. Fogel, Kirk R. Daffner	2020	2
6	Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics PLoS Biology ·Farah Bardai, and Dr. Samiyaiyah Nehru Jeevitha Selvi Karthikeyan, Rachel M. Bailey, 暢通奥野, Jada Lewis, Mel Β. Feany	2018	43
7	A Conserved Cytoskeletal Signaling Cascade Mediates Neurotoxicity of FTDP-17 Tau MutationsIn Vivo Journal of Neuroscience ·Farah Bardai, Liqun Wang, Bhasker Patel, Yenjerla Mythili, T. Chris Gamblin, Mel Β. Feany	2017	29
8	Functional screening in Drosophila identifies Alzheimer's disease susceptibility genes and implicates Tau-mediated mechanisms Human Molecular Genetics ·Joshua M. Shulman, Selina Imboywa, Νικόλαος Γιαγτζόγλου, Martin P. Powers, Yanling Hu, Danelle Devenport, Portia Chipendo, Lori B. Chibnik, Austin G. Diamond, Norbert Perrimon, Nicholas H. Brown, Philip L. De Jager, Mel Β. Feany	2013	118
9	Protein Misfolding and Oxidative Stress Promote Glial-Mediated Neurodegeneration in an Alexander Disease Model Journal of Neuroscience ·Liqun Wang, Kenneth J. Colodner, Mel Β. Feany	2011	58
10	New Approaches to the Pathology and Genetics of Neurodegeneration American Journal Of Pathology ·Mel Β. Feany	2010	10
11	Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo Molecular Brain ·Valerie Cullen, Maria Lindfors, Juliana Ng, Anders Paetau, Alois Keel, Yutaka OHGUCHI, Heather Boston, Paul Säftig, John Woulfe, Mel Β. Feany, Liisa Myllykangas, Michael G. Schlossmacher, Jaana Tyynelä	2009	236
12	Tyrosine and serine phosphorylation of α-synuclein have opposing effects on neurotoxicity and soluble oligomer formation Journal of Clinical Investigation ·Li Chen, Евгений Владимирович Кремнёв, Xu Wang, Alessandro Negro, Pamela J. McLean, Bradley T. Hyman, Mel Β. Feany	2009	171
13	α-Synuclein S129 Phosphorylation Mutants Do Not Alter Nigrostriatal Toxicity in a Rat Model of Parkinson Disease Journal of Neuropathology & Experimental Neurology ·Nikolaus R. McFarland, Zhanyun Fan, Kui Xu, Michael A. Schwarzschild, Mel Β. Feany, Bradley T. Hyman, Pamela J. McLean	2009	101
14	Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease Science ·Tiago F. Outeiro, В.Б. Барахнин, Stephen M. Altmann, Irina Kufareva, Katherine E. Strathearn, Allison Amore, Catherine B. Volk, Michele M. Maxwell, Jean‐Christophe Rochet, Pamela J. McLean, Anne B. Young, Ruben Abagyan, Mel Β. Feany, Bradley T. Hyman, Aleksey Kazantsev Hit paper breakdown →	2007	853
15	α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity Human Molecular Genetics ·В.Б. Барахнин, Jeffrey D. Parvin, Mel Β. Feany	2006	424
16	Parkin Neuron ·Mel Β. Feany, Leo J. Pallanck	2003	87
17	Studying Human Neurodegenerative Diseases in Flies and Worms Journal of Neuropathology & Experimental Neurology ·Mel Β. Feany	2000	24
18	Neurodegenerative disorders with extensive tau pathology: A comparative study and review Annals of Neurology ·Mel Β. Feany, Dennis W. Dickson	1996	221
19	Neuropathologic Overlap of Progressive Supranuclear Palsy, Pickʼs Disease and Corticobasal Degeneration Journal of Neuropathology & Experimental Neurology ·Mel Β. Feany, Linda A. Mattiace, Dennis W. Dickson	1996	209
20	Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy Acta Neuropathologica ·Mel Β. Feany, Hanna Ksiȩżak-Reding, V. N. Mincheva, Inez Vincent, S. -H. Yen, Dennis W. Dickson	1995	88

About Mel Β. Feany

Mel Β. Feany is a scholar working on Aging, Neurology, Neurology, Cellular and Molecular Neuroscience and Physiology, having authored 106 papers that have together received 13.4k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (35 papers), Alzheimer's disease research and treatments (35 papers), Cellular transport and secretion (15 papers), Neurological diseases and metabolism (10 papers), Mitochondrial Function and Pathology (10 papers), Genetic Neurodegenerative Diseases (10 papers), RNA regulation and disease (9 papers) and Nerve injury and regeneration (9 papers). The work is most often cited by research in Aging (714 citations), Neurology (5.2k citations), Cellular and Molecular Neuroscience (4.8k citations), Neurology (1.8k citations) and Physiology (4.8k citations). Mel Β. Feany has collaborated with scholars based in United States, Australia and Finland. Frequent co-authors include Welcome Bender, Dennis W. Dickson, Joshua M. Shulman, Li Chen, Joshua Shulman, Philip L. De Jager, Tudor A. Fulga, Jada Lewis, Jürgen Götz and Leo J. Pallanck. Their work appears in journals such as Journal of Neuroscience, Journal of Neuropathology & Experimental Neurology, Human Molecular Genetics, Nature Communications and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact